First-In-Human Phase I Study Of A Dual mTOR Kinase And DNA-PK Inhibitor (CC-115) In Advanced Malignancy

Overview of attention for article published in Cancer Management and Research, December 2019

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (55th percentile)
High Attention Score compared to outputs of the same age and source (84th percentile)

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 3,400 followers.

RT @PaperbirdsM: New article: First-In-Human Phase I Study Of A Dual mTOR Kinase And DNA-PK Inhibitor (CC-115) In Advanced Malignancy. http…

New article: First-In-Human Phase I Study Of A Dual mTOR Kinase And DNA-PK Inhibitor (CC-115) In Advanced Malignancy. https://t.co/VeVvLTd0PG #CLL #leusm #hematology

First-In-Human Phase I Study Of A Dual mTOR Kinase And DNA-PK Inhibitor (CC-115) In Advanced Malignancy. #lymphoma #lymsm https://t.co/9PgHyuStwk